Bioscience at its Roots
Members – Innovation – Growth
September 18th, Cooper Creek Event Center
8:45am – 9:30 – Registration, Breakfast, Networking
9:30 – Welcome Remarks
9:35-10 – Ohio’s Bio IQ: What’s the score?
Based on input from a range of scientific, industry and public policy sources, John F. Lewis, Jr., BioOhio’s President & CEO, outlines a unique perspective on the “State of the Biosciences in Ohio” as well as the U.S. and the rest of the world.
10-11 – The Canopy and the Roots – Innovation and R&D
Bioscience successes are similar to healthy trees: the large, visible canopy of the healthy organization has a substantial financial trunk, sturdy talent management and other logistical branches, leaves and fruit that are the public face and product of the organization. But without the breakthrough initial premise and follow-on discoveries made in the lab, many bioscience organizations struggle to see the light of day. It’s the novel, primary and applied research that is the foundational root that nurtures and supports the leafy returns above.
Join a distinguished panel of Ohio bio professionals for a peek at the evolving trends of innovation and R&D leading to better outcomes for more patients.
Moderated by John F. Lewis, Jr., President & CEO, BioOhio
- Jason E. Barkeloo, Founder & CEO, Bacterial Robotics
- Andrew Cothrel, CEO, NovoSource
- Daniel M. Miller, M.D., Ph.D., Medical Director, Cincinnati Eye Institute
- Sunnie Southern, MS, RD, LD, Founder and CEO, Viable Synergy, LLC and Creator, Innov8 for Health
11-11:15 – Break
11:15-12:25 – Transforming Healthcare
Demands on healthcare systems today are also transforming how bioscience companies need to think about product development, financing, partnerships, reimbursement, education, training, etc. Learn how the transformation is impacting all of the players in the continuum of healthcare and how it is redefining the roles of drug-makers, device manufacturers, patients, providers, and payers.
Moderated by Katherine “KC” McAllister, EVP, Business Operations, Taylor Strategy Partners
- Mike Carrel, President and CEO, AtriCure, Inc.
- Jack Kraeutler, CEO, Meridian Bioscience
- Don Wetherhold, President & CEO, Aprecia Pharmaceuticals
12:25-1:35 – Lunch, Networking
1:35-2:45 – Think globally, act regionally…and profit locally (Ohio’s Medical Corridor plus…)
Bioscience professionals must collaborate across a complex matrix of geographies, professional disciplines, and vested interests – sometimes even with a competitor – in order to succeed. It takes a family to grow your bioscience company.
Learn about a statewide clinical trials network and reciprocal IRB, VentureOhio’s efforts to increase angel and investment funds across the state, and lessons from others that will demonstrate strengths that differentiate Ohio and our neighbors from other regions and countries.
Moderated by Aaron Pitts, Managing Director, BioHealth & Agribusiness / Food Processing, JobsOhio
- Kathleen Hilliard, BA, CCRC, Manager, Clinical Trials Operations, Ohio Clinical Trials Collaborative (OCTC)
- Stephen Rapundalo, Ph.D., President & CEO, MichBio
- Frank Samuel, President, VentureOhio
2:45-4 – Living Success Stories through Financing, Exits, Sales, Exporting, Expansions
It’s a process that’s tried and true in multiple industries:
Success in bioscience relies on making decisions that respond intelligently to challenges unique to our industry – and the rules are changing every day. We’ll hear successful strategies that resulted in raising money, sales growth, an exit, an expansion or more.
Moderated by Adam Singer, Director, BioHealth Cluster, REDI Cincinnati
- Joseph Gardner Ph.D., President & CEO, Aerpio Therapeutics
- Jan Rosenbaum, Ph.D., Chief Scientific Officer, Airway Therapeutics
- David Scholl, Ph.D., BioOhio Board Chair and Partner, Athenian Ventures
4-4:10 – Closing Remarks
John F. Lewis, Jr., President & CEO, BioOhio
4:10-6 – Networking Reception
Enjoy networking, drinks and hors d’oeuvres.
Drawing for “Blue Ash Golf Course Round of 18 Foursome Package” at 5:15 (must be present to win).